CHTN_TNBC1- Triple Negative Breast Cancer

TMA Map

Map Code	Tissue Description	# of Cases*
Case #	Triple Negative Breast Cancer	36 (2 cores/case)
Placenta	Control Tissue - Placenta	2
Spleen	Control Tissue - Spleen	2
Liver	Control Tissue - Liver	2
Kidney	Control Tissue -Kidney	2
*This number represents the number of cases selected in the original design of the TMA. Each case is sampled two times with a 1 mm core. Due to the non-uniformity inherent to tissue samples and histologic techniques, not all cases will be represented in all of the TMA sections. For QA criteria, please refer to the TMA information sheet for this TMA.

Column	Description
Race	Black or white
Ethnicity	Hispanic or non-hispanic
Year of Diagnosis	Year of initial diagnosis (year)
Age at Diagnosis	Subject age at initial diagnosis
History of Cancer	Subject history of cancer (any type)
Time to Sample Collection (Days)	Time from primary diagnosis to tissue sample collection (TMA core)
Sample Location	Site of sample collection (TMA core)
**pTNM	Pathological Staging - neoadjuvant treatment indicated by "y" modifier
Largest Size of Invasive Cancer (cm)	Largest tumor size according to pathology report
Number of Positive Lymph Nodes	Number of positive lymph nodes according to pathology report
Grade	Tumor grade according to pathology report
Histologic Type	Ductal, lobular, metaplastic, mixed
Genetic Testing	Genetic testing results, if available
Last Cancer Status	Subject disease status at time of last contact (evidence of disease or no evidence of disease)
Last Vital Status	Deceased or alive
Cause of Death	Subject cause of death (unknown, died of disease, died from complications of disease, not applicable)
Survival Time (Years)	Elapsed time to death or last contact from the date of initial diagnosis
**American Joint Committee on Cancer Staging Manual, 8th Ed.